Company Lumosa Therapeutics Co., Ltd.

Equities

6535

TW0006535008

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
183.5 ^TWD	0.00%		-2.65%	+168.67%

05-14	Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson	CI
05-14	Lumosa Therapeutics Co., Ltd. Announces the Change in Juristic-Person Director Representative	CI

LUMOSA THERAPEUTICS CO., LTD. is a Taiwan-based company principally engaged in the development of new drugs. The Company is engaged in the development of new drugs for unmet medical needs in the fields of central nervous system (CNS), oncology, and inflammatory diseases. The Company is engaged in scientific licensing and new drug development under the reSEARCH and DEVELOPMENT model.

Number of employees: 47

TWD in Million	2022	Weight	2023	Weight	Delta
Novel Therapies and Solutions 100.0 %	27	100.0 %	57	100.0 %	+113.63%

TWD in Million	2022	Weight	2023	Weight	Delta
Asia 45.0 %	2	7.5 %	26	45.0 %	+1,180.25%
Taiwan 27.1 %	21	79.7 %	15	27.1 %	-27.46%
Europe 14.7 %	0	0.8 %	8	14.7 %	+3,818.31%
Americas 13.3 %	3	12.0 %	8	13.3 %	+137.01%

Managers	Title	Age	Since
Jung Chin Lin CEO	Chief Executive Officer	70	11-09-15
Chia Chi Yang DFI	Director of Finance/CFO	-	22-01-31
June Kuo CTO	Chief Tech/Sci/R&D Officer	-	-
Todd Ban PRN	Corporate Officer/Principal	-	-
Judy Juang PRN	Corporate Officer/Principal	-	-
Judy Chuang LAW	General Counsel	-	14-07-06

Members of the board	Title	Age	Since
Jung Chin Lin CEO	Chief Executive Officer	70	11-09-15
I Hsiung Chang BRD	Director/Board Member	-	16-01-25
Su Chi Wang BRD	Director/Board Member	-	14-07-24
Hai Yi Ma BRD	Director/Board Member	-	21-07-06
Te Fu Hsieh CHM	Chairman	-	-
Hsueh Ling Wang BRD	Director/Board Member	-	06-07-02
Chih Hsiung Wu BRD	Director/Board Member	-	18-06-13
Chih Yung Chin BRD	Director/Board Member	-	19-06-26
I Chi Kao BRD	Director/Board Member	-	18-06-13
Chong Hao Tsai BRD	Director/Board Member	-	20-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	164,973,825	86,332,825 ( 52.33 %)	0	52.33 %

Lumosa Therapeutics Co., Ltd.

No. 3-2, Yuanqu Street 4th Floor

115 03, Taipei

http://www.lumosa.com.tw

address Lumosa Therapeutics Co., Ltd.(6535)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

183.5 TWD

Average target price

233.3 TWD

Spread / Average Target

+27.16%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
LUMOSA THERAPEUTICS CO., LTD.	+168.67%	942M
VERTEX PHARMACEUTICALS INCORPORATED	+8.33%	113B
REGENERON PHARMACEUTICALS, INC.	+10.22%	106B
ARGENX SE	+0.41%	22.27B
BIONTECH SE	-11.90%	22.22B
GENMAB A/S	-5.99%	19.43B
WUXI APPTEC CO., LTD.	-37.36%	17.87B
BEIGENE, LTD.	-5.28%	17.24B
NEUROCRINE BIOSCIENCES, INC.	+7.67%	14.29B
SAREPTA THERAPEUTICS, INC.	+37.63%	12.52B

Bio Therapeutic Drugs